Medicare Enrolled

Dr. Rao Sunkavally, M.D.

Urology Physician · Fremont, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
1999 MOWRY AVE, Fremont, CA 94538
5107909025
In practice since 2008 (18 years)
NPI: 1760652184 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sunkavally from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sunkavally? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sunkavally

Dr. Rao Sunkavally is an urology physician in Fremont, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Sunkavally performed 3,787 Medicare services across 2,270 unique beneficiaries.

Between the years covered by Open Payments, Dr. Sunkavally received a total of $1,159 from 6 pharmaceutical and/or device companies across 47 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sunkavally is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 23% volume in CA $1,159 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,787
Medicare services
Top 23% in CA for urology physician
2,270
Unique beneficiaries
$71
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~210 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Urinalysis, manual
A manual laboratory examination of a urine sample to check for various substances and cells.
923 $3 $8
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
781 $120 $160
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
574 $85 $110
Limited abdominal ultrasound
A focused ultrasound examination of the abdomen to evaluate specific organs or areas. This procedure uses sound waves to create images of internal structures.
422 $92 $165
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
345 $12 $40
Electronic assessment of bladder emptying
A test that uses electronic monitoring to evaluate how well the bladder empties urine.
220 $13 $35
Leuprolide acetate (for depot suspension), 7.5 mg 150 $135 $300
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
114 $158 $250
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
69 $242 $350
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
63 $44 $75
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
61 $117 $200
Subcutaneous or intramuscular chemotherapy injection
This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle.
23 $36 $76
Cystourethroscopy for female urethral syndrome
An examination of the bladder and urethra using an endoscope to treat female urethral syndrome.
19 $336 $565
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
12 $72 $95
Urethral dilation using endoscope
A procedure to widen the urethra using a thin, lighted tube called an endoscope. This helps to open a narrowed urethral passage.
11 $335 $499
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,159
Total received (2018-2024)
Avg $166/year across 7 years
Bottom 37% in CA for urology physician
6
Companies
47
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$799 (68.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$360 (31.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$127
2023
$389
2022
$413
2021
$15
2020
$106
2019
$98
2018
$12

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$70
Astellas Pharma US Inc
$56
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$722
Janssen Biotech, Inc.
$313
AbbVie Inc.
$35
PFIZER INC.
$34
Boston Scientific Corporation
$28
Teleflex LLC
$26
Top 3 companies account for 92.4% of all-time payments
Associated products mentioned in payments ›
ERLEADA · Erleada · LUPRON DEPOT · Myrbetriq · SpaceOAR VUE System - 10mL · UroLift System · XTANDI · Xtandi
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (69%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware.

Looking for an urology physician in Fremont?
Compare urology physicians in the Fremont area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
138
Per 100K population
8.4
County median income
$126,240
Nearest hospital
WASHINGTON HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Sunkavally is a clinical cardiology specialist, with above-average Medicare volume (top 23% in CA), with speaking/promotional industry engagement, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Sunkavally experienced with urinalysis, manual?
Based on Medicare claims data, Dr. Sunkavally performed 923 urinalysis, manual services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sunkavally receive payments from pharmaceutical companies?
Yes. Dr. Sunkavally received a total of $1,159 from 6 companies across 47 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sunkavally's costs compare to other urology physicians in Fremont?
Dr. Sunkavally's average Medicare payment per service is $71. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sunkavally) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →